Fig. 2From: Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trialsNetwork plot for total number of collected CD34+ cells. Network plot depicting all direct comparisons in included trials with data about the total number of collected CD34+ cell (× 106/kg) for patients with MM (A) and NHL (B). Each node represents a mobilization regimen, while each line represents direct comparison between two regimens, with the thickness reflecting the number of times of direct comparisons. CY, cyclophosphamide; G-CSF, granulocyte colony-stimulating factor; ID-AraC, intermediate-dose cytarabine; RD, reduced dose; SD, standard dose; YF-H-2015005, a new CXCR4 antagonistBack to article page